Literature DB >> 11896205

Frameshift mutations of human gastrin receptor gene (hGARE) in gastrointestinal cancers with microsatellite instability.

Luigi Laghi1, Guglielmina Nadia Ranzani, Paolo Bianchi, Antonio Mori, Karl Heinimann, Ombretta Orbetegli, Marco Rondo Spaudo, Ombretta Luinetti, Simona Francisconi, Massimo Roncalli, Enrico Solcia, Alberto Malesci.   

Abstract

Gastrointestinal tumors with DNA mismatch repair (MMR) defects show microsatellite instability (MSI) and harbor frameshift mutations in coding mononucleotide repeats of cancer-related genes (targets). We assessed MSI status in 233 sporadic gastrointestinal tumors. We classified as MSI-H (high-frequency microsatellite instability) 15 (10%) of 150 colorectal cancers and 13 (16%) of 83 gastric cancers. We searched for frameshift mutations in a coding poly(T)(8) tract within the gastrin receptor gene (hGARE), which has a potential role in gastrointestinal carcinogenesis. To this purpose, we screened 43 unstable tumors (including 15 hereditary nonpolyposis colorectal cancer cases previously classified as MSI-H), 98 stable tumors, as well as 3 MMR-deficient and 4 MMR-proficient gastrointestinal cancer cell lines. We found mutations in 8 (19%) of the 43 MSI-H tumors but in none of the 98 stable cancers. hGARE mutation frequency was similar in gastric (23%) and colorectal cancers, including sporadic (13%) and hereditary (20%) cases. All mutated tumors proved to harbor frameshift mutations in other cancer-related genes that are considered as targets in MSI tumorigenesis. The MMR-deficient and gastrin-sensitive LoVo colorectal cancer cells also showed a hGARE heterozygous frameshift mutation, but expressed only the mutated allele. All detected mutations can be predicted to generate a truncated protein carrying amino acid changes. On the basis of genetic findings, we propose hGARE as a new candidate target gene in MSI tumorigenesis. Functional studies are warranted to elucidate the mechanism by which the hGARE mutation might contribute to gastrointestinal carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11896205     DOI: 10.1038/labinvest.3780420

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  4 in total

1.  Tumor budding as a potential histopathological biomarker in colorectal cancer: hype or hope?

Authors:  Fabio Grizzi; Giuseppe Celesti; Gianluca Basso; Luigi Laghi
Journal:  World J Gastroenterol       Date:  2012-12-07       Impact factor: 5.742

Review 2.  Gastrin - active participant or bystander in gastric carcinogenesis?

Authors:  Susan A Watson; Anna M Grabowska; Mohamad El-Zaatari; Arjun Takhar
Journal:  Nat Rev Cancer       Date:  2006-12       Impact factor: 60.716

3.  A novel gene, GCRG224, is differentially expressed in human gastric mucosa.

Authors:  Gang-Shi Wang; Meng-Wei Wang; Ben-Yan Wu; Wei-Di You; Xin-Yan Yang
Journal:  World J Gastroenterol       Date:  2003-01       Impact factor: 5.742

4.  Irrelevance of microsatellite instability in the epidemiology of sporadic pancreatic ductal adenocarcinoma.

Authors:  Luigi Laghi; Stefania Beghelli; Antonino Spinelli; Paolo Bianchi; Gianluca Basso; Giuseppe Di Caro; Anna Brecht; Giuseppe Celesti; Giona Turri; Samantha Bersani; Guido Schumacher; Christoph Röcken; Ilona Gräntzdörffer; Massimo Roncalli; Alessandro Zerbi; Peter Neuhaus; Claudio Bassi; Marco Montorsi; Aldo Scarpa; Alberto Malesci
Journal:  PLoS One       Date:  2012-09-21       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.